Prothena reported 607.53M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Adamas Pharmaceuticals ADMS:US 108M 7.65M
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Akebia Therapeutics AKBA:US $ 330.08M 0.99M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
ALKERMES ALKS:US 1.05B 15.25M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Amgen AMGN:US $ 24380M 5281M
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Exelixis EXEL:US $ 1662.03M 68.78M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Intra Cellular Therapies ITCI:US $ 533.24M 68.06M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Macrogenics MGNX:US $ 334.7M 32.3M
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Prothena PRTA:US 607.53M 198.06M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
Vital Therapies VTL:US $ 122.5M 20.81M
Xoma XOMA:US $ 74.87M 12.38M
YTE INCY:US $ 2923.8M 303.74M